{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:30:02Z","timestamp":1777419002787,"version":"3.51.4"},"reference-count":48,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>High rates of antibiotic prescribing in children lead to antibiotic resistance in the community. Surveillance on utilization rates and comparisons with other jurisdictions are methods for benchmarking. Surveillance on antibiotic use is well established in Europe, including Denmark, but until recently, similar data from Canada were lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To compare pediatric antibiotic prescribing rates in British Columbia, Canada, with those in Denmark.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Population-based data on antibiotic prescriptions from British Columbia and Denmark were obtained from 1999 to 2003 for children less than 15 years of age. Annual trends in prescription rates per 1000 children were analyzed by using generalized linear models for all children less than 15 years of age; they were stratified by age group (0\u20134, 5\u20139, 10\u201314 y) for all antibiotics. Class-specific trends were also evaluated for penicillins, cephalosporins, macrolides, sulfonamides and trimethoprim, tetracyclines, and fluoroquinolones.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From 1999 to 2003, the overall British Columbia prescription rate was significantly higher than that of Denmark (p &lt; 0.0001) at all age stratifications. In 2003, the British Columbia prescription rate was twice that of Denmark, at 608 versus 385 prescriptions per 1000 children, respectively. In both jurisdictions, the majority of antibiotics used were penicillins (Anatomical Therapeutic Chemical class J01C), However, in British Columbia, most penicillins used were extended-spectrum (83% in 2003); in Denmark, 34% of penicillins used in 2003 were extended-spectrum and 56% were \u03b2-lactamase sensitive. In British Columbia, use of penicillins (\u22124.5%), cephalosporins (\u22125.5%), trimethoprim\/sulfamethoxazole (\u221236%), and tetracycline (\u22121.6%) decreased over time, whereas in Denmark, use of penicillins increased by 11% over time and non-penicillin antibiotics remained stable. A significant increase in macrolide consumption was seen in British Columbia due to use of clarithromycin and azithromycin; in contrast, macrolide consumption declined in Denmark.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Compared with Denmark, the antibiotic prescription rate for children is substantially higher in British Columbia. In addition, there has been a significant increase in the use of macrolides, especially the second-generation agents, in British Columbia compared with the use in Denmark. Further studies are required to delineate reasons for antibiotic prescribing patterns in these 2 jurisdictions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1h293","type":"journal-article","created":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T20:08:25Z","timestamp":1174421305000},"page":"659-666","source":"Crossref","is-referenced-by-count":20,"title":["A Comparison of Antibiotic Use in Children Between Canada and Denmark"],"prefix":"10.1177","volume":"41","author":[{"given":"Fawziah","family":"Marra","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia; Director, Vaccine and Pharmacy Services, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique L","family":"Monnet","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance Surveillance Unit, National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M","family":"Patrick","sequence":"additional","affiliation":[{"name":"Communicable Disease Epidemiology, British Columbia Centre for Disease Control; Associate Professor, Health Care and Epidemiology, University of British Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Chong","sequence":"additional","affiliation":[{"name":"Communicable Disease Epidemiology, British Columbia Centre for Disease Control"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian T","family":"Brandt","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance Surveillance Unit, National Center for Antimicrobials and Infection Control, Statens Serum Institut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Winters","sequence":"additional","affiliation":[{"name":"Health Care and Epidemiology, University of British Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit S","family":"Kaltoft","sequence":"additional","affiliation":[{"name":"National Streptococcus Reference Laboratory, Statens Serum Institut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J","family":"Tyrrell","sequence":"additional","affiliation":[{"name":"National Centre for Streptococcus; Associate Professor, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite","family":"Lovgren","sequence":"additional","affiliation":[{"name":"National Centre for Streptococcus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R","family":"Bowie","sequence":"additional","affiliation":[{"name":"University of British Columbia; Division of Infectious Diseases, Department of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2007,4,1]]},"reference":[{"key":"bibr1-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520270048030"},{"key":"bibr2-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198807000-00013"},{"key":"bibr3-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.23.3096"},{"key":"bibr4-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.156.11.1114"},{"key":"bibr5-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.3.620"},{"key":"bibr6-aph.1H293","volume":"8","author":"Ferech M","year":"2004","journal-title":"Eurosurveillance Weekly"},{"key":"bibr7-aph.1H293","unstructured":"European Surveillance of Antimicrobial Consumption (ESAC). www.ua.ac.be\/esac (accessed 2005 Sept 28)."},{"key":"bibr8-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-0311"},{"key":"bibr9-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1031630"},{"key":"bibr10-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00394-1"},{"key":"bibr11-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.6.959"},{"key":"bibr12-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.5.767"},{"key":"bibr13-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-005-1738-4"},{"key":"bibr14-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-005-1737-5"},{"key":"bibr15-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200308001-00002"},{"key":"bibr16-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2004.10.009"},{"key":"bibr17-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17907-0"},{"key":"bibr18-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04972-2"},{"key":"bibr19-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1086\/420825"},{"key":"bibr20-aph.1H293","volume-title":"Medstat"},{"key":"bibr21-aph.1H293","volume-title":"ATC\/DDD index 2005","year":"2005"},{"key":"bibr22-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0706-z"},{"key":"bibr23-aph.1H293","doi-asserted-by":"publisher","DOI":"10.3201\/eid0812.010533"},{"key":"bibr24-aph.1H293","unstructured":"Workshop 2: list of possible determinants of antibiotic use and sources of data. European Conference on Antibiotic Use in Europe, Brussels, Belgium, November 15\u201317, 2001. www.ua.ac.be\/main.aspx?c=*ESAC2&n=21673 (accessed 2005 Aug 2)."},{"key":"bibr25-aph.1H293","unstructured":"British Columbia annual summary of reportable diseases 2004. www.bccdc.org (accessed 2005 Sept 28)."},{"key":"bibr26-aph.1H293","unstructured":"World Health Organization Regional Office for Europe. Health for All database (updated June 2005). http:\/\/data.euro.who.int\/hfadb\/ (accessed 2005 Aug 2)."},{"key":"bibr27-aph.1H293","first-page":"4032","volume":"165","author":"B\u2298gh H","year":"2003","journal-title":"Ugeskr L\u00e6ger"},{"key":"bibr28-aph.1H293","unstructured":"ETwo year old immunizations, 2004 birth cohort. www.bccdc.org (accessed 2005 Sept 28)."},{"key":"bibr29-aph.1H293","volume-title":"Statistikbanken"},{"key":"bibr30-aph.1H293","unstructured":"Amtr\u00e5dsforeningen. Amtr\u00e5dforeningens statistikdatabase. www.arf.dk\/Vidensbank\/Statistikdatabase.htm (accessed 2005 Aug 2)."},{"key":"bibr31-aph.1H293","unstructured":"2001 census profiles, BC STATS. www.bcstats.gov.bc.ca\/data\/cen01\/profiles\/59000000.pdf (accessed 2005 Sept 28)."},{"key":"bibr32-aph.1H293","unstructured":"P.E.O.P.L.E. Projection 28 (Population Extrapolation for Organizational Planning with Less Error). Health Data Warehouse Release Date: September 2003. https:\/\/webapps.hnet.bc.ca\/hdw\/hdw_db\/hdw.HomePkg.ShowPage (accessed 2005 Sept 28)."},{"key":"bibr33-aph.1H293","unstructured":"Ministry of Science Technology and Innovation. Pregnancy and birth. www.workindenmark.dk\/Pregnancy_birth\/0\/4\/0 (accessed 2005 Aug 2)."},{"key":"bibr34-aph.1H293","unstructured":"Human resources and skills development. Monitoring and assessment report for 2004. www.hrsdc.gc.ca\/en\/ei\/reports\/eimar_2004.shtml (accessed 2005 Sept 28)."},{"key":"bibr35-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7124.21"},{"key":"bibr36-aph.1H293","unstructured":"National Breastfeeding Centre Denmark. The breastfeeding situation\u2014in short. www.videocenterforamning.dk\/htm\/english\/menu_english.html#Anchor-Th-21377 (accessed 2007 Mar 7)."},{"key":"bibr37-aph.1H293","unstructured":"BC Reproductive Care Program. Annual Report 2004. www.rcp.gov.bc.ca\/bcrcpreports.htm (accessed 2005 Sept 28)."},{"key":"bibr38-aph.1H293","unstructured":"Statistics Canada, National Population Health Survey, 1994 data. www.statcan.ca\/English\/Dli\/Data\/Ftp\/nphs\/nphs1994.htm"},{"key":"bibr39-aph.1H293","volume-title":"Structural Monitoring\u2014International Benchmarking of Denmark","author":"The Danish Government.","year":"2000"},{"key":"bibr40-aph.1H293","unstructured":"Statistics Canada. 2000\/01 Child care report. www.statcan.ca\/Daily\/English\/050207\/d050207b.htm (accessed 2005 Sept 28)."},{"key":"bibr41-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh501"},{"key":"bibr42-aph.1H293","doi-asserted-by":"publisher","DOI":"10.1086\/501778"},{"key":"bibr43-aph.1H293","unstructured":"BC Pharmacare General Information. www.healthservices.gov.bc.ca\/pharme\/ (accessed 2005 May 13)."},{"key":"bibr44-aph.1H293","unstructured":"Danish Medicines Agency. New rules on reimbursement for medicinal products as of 1 April 2005. www.laegemiddelstyrelsen.dk\/publikationer\/netpub\/UK\/reports\/medicintilskudsfolder_UK1\/pdf\/Medicintilskudsfolder_UK1.pdf (accessed 2005 Aug 2)."},{"key":"bibr45-aph.1H293","unstructured":"Danish Medicines Agency. Opdateret liste over l\u00e6gemidler med tilskud. www.laegemiddelstyrelsen.dk\/db\/filarkiv\/5019\/LaegemidlerMedTilskud.xls (accessed 2005 Aug 2)."},{"key":"bibr46-aph.1H293","first-page":"856","volume-title":"L\u00e6geforeningens Medicinfortegnelse 2002\/2003","author":"Justesen T","year":"2002","edition":"25"},{"key":"bibr47-aph.1H293","volume-title":"Otitis media: antibiotic therapy. Guideline notes","year":"2005"},{"issue":"2","key":"bibr48-aph.1H293","first-page":"70","volume":"11","author":"Mera R","year":"2005","journal-title":"Clin Microbiol Infect"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1H293","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1H293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:08:58Z","timestamp":1777374538000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1H293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1345\/aph.1H293"],"URL":"https:\/\/doi.org\/10.1345\/aph.1h293","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}